Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mil Med ; 181(8): 878-82, 2016 08.
Article in English | MEDLINE | ID: mdl-27483527

ABSTRACT

During the 1918-1919 pandemic, influenza mortality widely varied across populations and locations. Records of U.S. military members in mobilization camps (n = 40), military academies, and officer training schools were examined to document differences in influenza experiences during the fall 1918. During the fall-winter 1918-1919, mortality percentages were higher among soldiers in U.S. Army mobilization camps (0.34-4.3%) than among officer trainees (0-1.0%). Susceptibility to infection and clinical expressions of 1918 pandemic influenza varied largely based on host epidemiological characteristics rather than the inherent virulence of the virus.


Subject(s)
Influenza A Virus, H1N1 Subtype/pathogenicity , Influenza Pandemic, 1918-1919/history , Influenza, Human/mortality , Education/statistics & numerical data , History, 20th Century , Humans , Influenza, Human/epidemiology , United States/epidemiology
2.
Mol Endocrinol ; 26(10): 1757-72, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22915827

ABSTRACT

We describe a negative feedback autocrine regulatory circuit for glucose-stimulated insulin secretion in purified human islets in vitro. Using chronoamperometry and in vitro glucose-stimulated insulin secretion measurements, evidence is provided that dopamine (DA), which is loaded into insulin-containing secretory granules by vesicular monoamine transporter type 2 in human ß-cells, is released in response to glucose stimulation. DA then acts as a negative regulator of insulin secretion via its action on D2R, which are also expressed on ß-cells. We found that antagonism of receptors participating in islet DA signaling generally drive increased glucose-stimulated insulin secretion. These in vitro observations may represent correlates of the in vivo metabolic changes associated with the use of atypical antipsychotics, such as increased adiposity.


Subject(s)
Autocrine Communication , Dopamine/physiology , Insulin/metabolism , Adult , Animals , Antipsychotic Agents/pharmacology , Benzodiazepines/pharmacology , Blood Glucose , Cells, Cultured , Clozapine/pharmacology , Dopamine/metabolism , Dopamine D2 Receptor Antagonists , Dopamine Plasma Membrane Transport Proteins/antagonists & inhibitors , Dopamine Plasma Membrane Transport Proteins/genetics , Dopamine Plasma Membrane Transport Proteins/metabolism , Feedback, Physiological , Gene Expression , Glucose/physiology , Humans , Insulin/genetics , Insulin Secretion , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/metabolism , Male , Olanzapine , Pancreas/cytology , Pancreas/metabolism , Protein Transport , Rats , Rats, Sprague-Dawley , Rats, Zucker , Receptors, Dopamine D2/genetics , Receptors, Dopamine D2/metabolism , Tetrabenazine/pharmacology , Vesicular Monoamine Transport Proteins/antagonists & inhibitors , Vesicular Monoamine Transport Proteins/genetics , Vesicular Monoamine Transport Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...